Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Cisplatin + Pembrolizumab + Pemetrexed & Non-small-cell lung cancer (NSCLC) (Non-squamous Cell Carcinoma), the FDA label for pembrolizumab includes use “in combination with pemetrexed and platinum chemotherapy” (e.g., Cisplatin + Pembrolizumab + Pemetrexed) for first‑line treatment of metastatic Non-small-cell lung cancer (NSCLC) (Non-squamous Cell Carcinoma)with no EGFR or ALK genomic tumor aberrations, based on KEYNOTE‑189; in that trial, the platinum was carboplatin or cisplatin, so both are encompassed in the indication (1, 2).
The [European Commission…